#pharmaceutical
Related Stories (11)
EyePoint's drug for age-related eye disease fails late-stage trial, shares tank - Reuters
EyePoint's drug for age-related eye disease fails late-stage trial, shares tank Reuters
August 17, 2026'No discussions' over AstraZeneca-Bristol Myers deal, senior source says - Reuters
'No discussions' over AstraZeneca-Bristol Myers deal, senior source says Reuters
August 5, 2026Eli Lilly to offer early access to next-gen obesity drug to some patients - Reuters
Eli Lilly to offer early access to next-gen obesity drug to some patients Reuters
August 3, 2026Novo Nordisk's anti-inflammatory drug fails to reduce cardiovascular risk in late-stage trial - Reuters
Novo Nordisk's anti-inflammatory drug fails to reduce cardiovascular risk in late-stage trial Reuters
July 31, 2026Merck's cholesterol pill gets US FDA approval - Reuters
Merck's cholesterol pill gets US FDA approval Reuters
July 16, 2026Celcuity shares fall as launch delay eclipses US approval for breast cancer drug - Reuters
Celcuity shares fall as launch delay eclipses US approval for breast cancer drug Reuters
July 15, 2026US FDA declines to approve Achieve Life Sciences' smoking-cessation drug - Reuters
US FDA declines to approve Achieve Life Sciences' smoking-cessation drug Reuters
June 22, 2026US FDA approves J&J's oral psoriasis pill - Reuters
US FDA approves J&J's oral psoriasis pill Reuters
March 18, 2026Novo Nordisk to halve US list price of Wegovy from 2027 - Reuters
Novo Nordisk to halve US list price of Wegovy from 2027 Reuters
February 24, 2026Novo Nordisk's obesity drug CagriSema falls short against Eli Lilly's in trial - Reuters
Novo Nordisk's obesity drug CagriSema falls short against Eli Lilly's in trial Reuters
February 23, 2026Trump meets Novartis CEO, says drugmaker building 11 US plants - Reuters
<a href="https://news.google.com/rss/articles/CBMiqgFBVV95cUxQWkRNOGVDMjdOeVNCcTZaWXAyQ1Jld0RoTnZYR19TUTMwQXpqTUdtZHVxUWR6blNTbG9hTFdnV0pjRGtWVWl6aU9CWjM4THZYN0tMZHBMd0w4ajFDT0NjbkwybjJXeFFObUZSMmZ0TTdLWVlId0oxLUE2OFNkUUFvaUJwel96U0VQZjJJbW5EcUhpZHpDRmI5N09FOEw3a0FsbmsxcGNla3NSdw?oc=5" target="_blank">Trump meets Novartis CEO, says drugmaker building 11 US plants</a> <font color="#6f6f6f">Reuters</font>
February 20, 2026Related Pages (8)
Untitled
window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa
Untitled
window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa
Untitled
window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa
Untitled
window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa
Untitled
window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa
Untitled
window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa
Novo Nordisk’s obesity drug falls short against Eli Lilly’s in trial
Novo Nordisk said on Monday its experimental obesity drug CagriSema did not meet the primary endpoint in a trial designed to show it was non-inferior to competitor Eli Lilly’s tirzepatide in reducing
Untitled
window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa